Variable Hematoloji / İç Hastalıkları

Diagnostic Approach to Splenomegaly and the Decision for Splenectomy

Splenomegaly is not a disease but a finding with an UNDERLYING CAUSE; therefore, the main task is not to detect the enlarged spleen but to FIND THE CAUSE. Causes are grouped according to five mechanisms, and this grouping narrows the diagnostic search: (1) CONGESTION (portal hypertension, liver cirrhosis, heart failure, portal and splenic vein thrombosis); (2) INFECTION (infectious mononucleosis, tuberculosis, brucellosis, infective endocarditis, VISCERAL LEISHMANIASIS, MALARIA, HIV); (3) INFILTRATION (lymphoma, leukemias, myeloproliferative neoplasms, metastasis, amyloidosis, STORAGE DISEASES); (4) IMMUNE and INFLAMMATORY (autoimmune diseases, sarcoidosis, Felty syndrome); (5) INCREASED DESTRUCTIVE FUNCTION (chronic hemolytic anemias).

MASSIVE SPLENOMEGALY carries a separate diagnostic value and significantly narrows potential causes: primary myelofibrosis, chronic myeloid leukemia, hairy cell leukemia, major thalassemia, GAUCHER DISEASE, VISCERAL LEISHMANIASIS, and malaria-associated conditions. In our country, visceral leishmaniasis, brucellosis, malaria, and GAUCHER DISEASE should be particularly considered because all are treatable and are diagnosed late if not considered.

THE DECISION FOR SPLENECTOMY is limited to selected indications and is IRREVERSIBLE; vaccination is mandatory before the procedure, and thereafter the risk of INFECTION and THROMBOSIS persists lifelong.

Rapid management

Splenomegaly is a finding; INVESTIGATE THE CAUSE.
Evaluate the five mechanism groups in order:
CONGESTION (liver disease, portal hypertension, heart failure, portal/splenic vein thrombosis — liver tests, imaging, Doppler), INFECTION (mononucleosis, TUBERCULOSIS, BRUCELLOSIS, endocarditis, VISCERAL LEISHMANIASIS, MALARIA, HIV — fever and travel/living history), INFILTRATION (lymphoma, leukemia, myeloproliferative neoplasm, amyloidosis, GAUCHER — blood count, PERIPHERAL SMEAR, flow cytometry), IMMUNE/INFLAMMATORY (autoimmune diseases, sarcoidosis, Felty), INCREASED DESTRUCTION (chronic hemolysis — reticulocyte, lactate dehydrogenase, Coombs).
MASSIVE splenomegaly narrows the list: primary myelofibrosis, CML, hairy cell leukemia, major thalassemia, GAUCHER, visceral leishmaniasis, malaria.
SPECIFICALLY CONSIDER IN OUR COUNTRY: fever + splenomegaly + PANCYTOPENIA → VISCERAL LEISHMANIASIS; splenomegaly + THROMBOCYTOPENIA (malignancy not found) → GAUCHER DISEASE (diagnosed by enzyme test, relevant protocol).
SPLENECTOMY: the decision is limited to selected indications and is IRREVERSIBLE; CAPSULATED BACTERIAL VACCINES should be administered beforehand, and lifelong infection and THROMBOSIS risk should be monitored afterward (asplenia protocol).
EMERGENCY: trauma or sudden abdominal pain and hypotension in a massive spleen → SPLENIC RUPTURE.

Drug	Adult	Pediatric	Route	Duration
Confirmation and initial evaluation of splenomegaly The first step in the evaluation of splenomegaly is to confirm the finding; assessing spleen size by examination is not reliable, especially in obese patients and mild enlargements, so it should be verified and measured with imaging. Documenting the size is necessary not only for diagnosis but also for follow-up; response to treatment is often monitored by changes in spleen size. The second step is to gather basic information that will guide the diagnostic work-up. Peripheral smear is particularly valuable at this stage because it can show findings that directly lead to a diagnosis, such as leukoerythroblastic picture, blasts, atypical lymphocytes, schistocytes, and parasites. History of B symptoms such as fever, weight loss, and night sweats suggests malignancy and chronic infections; travel and living history are especially important in our country because visceral leishmaniasis, brucellosis, and malaria have geographical distribution. History of alcohol use and liver disease suggests congestive causes, while family history brings to mind hereditary hemolytic anemias and storage diseases.	Suspicious splenomegaly on examination (palpation and percussion) is confirmed with IMAGING and the size is measured. Complete blood count and PERIPHERAL SMEAR, liver function tests, lactate dehydrogenase, C-reactive protein, reticulocyte, protein electrophoresis; history of FEVER, weight loss, night sweats, TRAVEL and LIVING HISTORY, alcohol use, medications, and family history are questioned.	In children, the spleen can be palpated physiologically; normal sizes according to age should be used.	—	Until the diagnosis is made
Mechanism-based differential diagnosis There are many causes of splenomegaly, and this abundance disperses the diagnostic search without a systematic framework. Mechanism-based grouping solves this problem because it asks why the spleen is enlarging. In congestion, the problem is not in the spleen itself but in the outflow; portal hypertension is the most common cause, and findings of liver disease accompany it. In infections, the spleen enlarges as part of the immune response; fever and systemic findings guide the diagnosis. In infiltration, the splenic tissue fills with abnormal cells or deposits; blood count and peripheral smear are the most effective tools in this group. In immune and inflammatory causes, the spleen enlarges in response to increased immune activity. In increased destruction function, the spleen expands to clear erythrocytes with shortened lifespans; it is seen in chronic hemolytic anemias. This framework determines which tests should be requested and helps to avoid unnecessary extensive panels. Some patients have more than one mechanism present; for example, in a patient with cirrhosis, both congestion and hypersplenism are effective.	Five groups are evaluated in order: CONGESTION (liver tests, abdominal imaging, portal and splenic vein Doppler, echocardiography), INFECTION (blood culture, brucella and EBV serology, tuberculosis evaluation, HIV test, thick smear and thin smear for malaria, leishmaniasis serology), INFILTRATION (flow cytometry, bone marrow examination, imaging), IMMUNE/INFLAMMATORY (autoimmune markers), HEMOLYSIS (reticulocyte, lactate dehydrogenase, haptoglobin, direct Coombs)	In children, infections and hereditary hemolytic anemias stand out; storage diseases should also be evaluated	—	Diagnostic evaluation
Narrowed list in massive splenomegaly The degree of spleen enlargement carries diagnostic information. There are many causes of mild and moderate splenomegaly, and differentiation is difficult; in contrast, massive splenomegaly is seen in only a few conditions where the spleen has been stimulated or filled intensely and for a long time. Therefore, when massive enlargement is detected, the list of possibilities narrows significantly and the diagnostic search accelerates. The common feature of the diseases on the list is their chronicity: in myeloproliferative neoplasms, extramedullary hematopoiesis and clonal infiltration; in hairy cell leukemia, involvement of the splenic red pulp; in thalassemia major, years of hemolysis and extramedullary hematopoiesis; in Gaucher disease, storage of accumulated material in macrophages; and in visceral leishmaniasis and chronic malaria, continuous immune stimulation plays a role. Gaucher disease and visceral leishmaniasis should be specially emphasized in this list because both are treatable and, if not considered, can be followed for years as "idiopathic" (relevant protocols).	In massive splenomegaly, PRIMARy MYELOFIBROSIS, CHRONIC MYELOID LEUKEMIA, HAIRY CELL LEUKEMIA, BETA-THALASSEMIA MAJOR, GAUCHER DISEASE, VISCERAL LEISHMANIASIS, and malaria-related conditions are primarily evaluated; blood count, peripheral smear, molecular tests related to BCR::ABL1 and JAK2, GLUCOSEREBROSIDASE ENZYME ACTIVITY, and leishmaniasis investigation are planned.	In children, thalassemia major, storage diseases, visceral leishmaniasis, and juvenile myelomonocytic leukemia are highlighted (relevant protocols)	—	Diagnostic evaluation
Diagnoses that should especially be considered in our country The differential diagnosis of splenomegaly varies by geography, and the order listed in international sources cannot be directly applied to the practice in our country. Visceral leishmaniasis is seen in some regions of our country and its clinical picture closely mimics hematologic malignancies: prolonged fever, prominent splenomegaly, and pancytopenia. These patients are often evaluated with suspicion of lymphoma or leukemia, and the diagnosis depends on searching for amastigotes in bone marrow examination; if this possibility is not reported to the laboratory, the finding can easily be overlooked. If untreated, it progresses fatally. Gaucher disease, on the other hand, is missed for a different reason: in cases of splenomegaly and thrombocytopenia, hematologic malignancies are investigated first, and if the results are inconclusive, the patient is followed as 'idiopathic.' However, a single enzyme test can make the diagnosis, and the disease can be effectively treated. Brucellosis, tuberculosis, and malaria are also diagnoses that are overlooked if the history is not thoroughly reviewed. The common feature of these four conditions is that all are treatable, and their diagnosis depends on coming to mind.	FEVER + SPLENOMEGALY + PANCYTOPENIA → VISCERAL LEISHMANIASIS (amastigotes in the bone marrow and serology). SPLENOMEGALY + THROMBOCYTOPENIA, if malignancy is not found → GAUCHER DISEASE (GLUCOSEREBROSIDASE ENZYME ACTIVITY; a simple and definitive test). Additionally, BRUCELLOSIS, TUBERCULOSIS, and MALARIA are evaluated together with the history	In children, visceral leishmaniasis may be confused with growth retardation; Gaucher disease can also be diagnosed in childhood	—	Diagnostic evaluation
Decision for splenectomy and preoperative preparation Splenectomy is an irreversible decision, and this feature determines the nature of the decision. The spleen plays a unique role in defending against encapsulated bacteria and clearing abnormal circulating cells; when removed, these functions cannot be fully replaced. Therefore, in every patient considered for splenectomy to correct cytopenias, the underlying disease should be treated first. In some diseases, this principle is particularly important: in Gaucher disease, splenectomy is avoided today because it worsens bone and lung involvement; in immune thrombocytopenia, the place of splenectomy has narrowed with increasing effective medical treatment options. When the decision is made, the most critical preparation is vaccination, and this should be planned before the procedure because post-splenectomy vaccine response is weaker. The patient should be given a card indicating asplenia, clearly informed about what to do in case of fever, and provided with an emergency antibiotic plan. In the postoperative period, the risk of thrombosis increases, and care should be taken regarding portal vein thrombosis.	The decision for splenectomy is limited to SELECTED indications, and the treatment of the underlying disease is primarily attempted. Once the decision is made, PREOPERATIVE vaccination against encapsulated bacteria is administered (pneumococcus, Haemophilus influenzae type b, meningococcus), and timing is planned according to national immunization recommendations; the patient is given an ASPLENIA CARD and an emergency plan (asplenia protocol).	In children, splenectomy is avoided or delayed as much as possible; partial splenectomy is considered in selected cases.	—	There are lifelong consequences.

Alternative

Partial splenectomy and splenic embolization are considered in selected patients to preserve part of spleen function; it depends on experience and center facilities.
The first approach to cytopenias due to hypersplenism is the treatment of the underlying disease; the degree of cytopenia alone is not a reason for intervention (hypersplenism protocol).
In Gaucher disease, enzyme replacement and substrate reduction therapy reduce splenomegaly; splenectomy should be avoided (relevant protocol).
In myeloproliferative neoplasms, JAK inhibitors reduce spleen size and symptoms; splenectomy is limited to selected and resistant cases (relevant protocols).
In splenomegaly due to portal hypertension, treatment is directed at liver disease and portal pressure; splenectomy is not a routine solution (relevant protocol).
In traumatic spleen injury, spleen-preserving approaches are preferred as much as possible today; the decision belongs to the surgical team.

Red flags

FEVER + SPLENOMEGALY + PANCYTOPENIA → VISCERAL LEISHMANIASIS; it mimics hematological malignancy, amastigotes should be searched in the bone marrow, and this possibility must be REPORTED TO THE LABORATORY (relevant protocol).
SPLENOMEGALY + THROMBOCYTOPENIA, if malignancy cannot be found → GAUCHER DISEASE; a simple ENZYME TEST establishes the diagnosis and the disease can be TREATED (relevant protocol).
Sudden and severe abdominal pain, hypotension, or pain radiating to the shoulder in massive splenomegaly → SPLEEN RUPTURE or INFARCTION; urgent evaluation is required.
Continuing contact sports in a patient diagnosed with infectious mononucleosis → risk of SPLEEN RUPTURE; a written warning should be given (relevant protocol).
BLAST in peripheral smear, leukoerythroblastic picture, or prominent BASOPHIL → hematologic malignancy; urgent hematology evaluation is required (relevant protocols).
Splenomegaly + marked cytopenia + monocytopenia → HAIRY CELL LEUKEMIA; monocytopenia is a strong clue and is often overlooked (relevant protocol).
Failure to VACCINATE before splenectomy → lifelong risk of encapsulated bacterial sepsis; vaccines should be planned BEFORE the procedure (asplenia protocol).
Performing splenectomy in Gaucher disease → WORSENS BONE and LUNG involvement; this diagnosis should be excluded in every patient considered for splenectomy due to thrombocytopenia.
Abdominal pain and clinical deterioration after splenectomy → PORTAL VEIN THROMBOSIS; the risk of thrombosis is increased during this period.
In a cirrhotic patient, new and rapidly growing spleen with worsening cytopenias → portal/splenic vein thrombosis or accompanying hematologic disease should be investigated.

Disposition and follow-up

Green zone: Patient with mild splenomegaly, asymptomatic, with normal or mildly affected blood count: outpatient evaluation, planning mechanism-based tests, documenting size by imaging, follow-up appointment.
Yellow zone: Splenomegaly with fever, marked cytopenia, massive splenomegaly, or diagnostic uncertainty: hematology and, if necessary, infectious disease evaluation, planning advanced tests including bone marrow examination, multidisciplinary discussion of splenectomy decision.
Red zone: Suspicion of spleen rupture or infarction, bleeding or infection with severe cytopenia, rapidly deteriorating febrile condition: urgent hospital admission, immediate imaging and treatment, joint evaluation by surgery and hematology.

Key clinical points

READ FIRST — five mechanisms, narrowing list

1) CONGESTION: portal hypertension, cirrhosis, heart failure, portal/splenic vein thrombosis | 2) INFECTION: mononucleosis, TUBERCULOSIS, BRUCELLOSIS, endocarditis, VISCERAL LEISHMANIASIS, MALARIA, HIV | 3) INFILTRATION: lymphoma, leukemias, myeloproliferative neoplasms, amyloidosis, GAUCHER | 4) IMMUNE/INFLAMMATORY: autoimmune diseases, sarcoidosis, Felty | 5) INCREASED DESTRUCTION: chronic hemolytic anemias

The causes of splenomegaly are so many that memorizing them in a list is practically useless; in contrast, asking why the spleen is enlarged makes the search manageable. In congestion, the problem is not with the spleen itself but with the blood outflow; portal hypertension is the most common cause and accompanies signs of liver disease, so liver tests and Doppler imaging should be requested early. In infections, the spleen enlarges as part of the immune response, and fever with systemic findings accompanies the condition. In infiltration, the splenic tissue fills with abnormal cells or deposits; in this group, blood count and peripheral smear are the most efficient tools because clues are often also found in the circulation. In immune and inflammatory causes, increased immune activity enlarges the spleen. In increased destruction, the spleen enlarges to clear erythrocytes with a shortened lifespan. This framework determines which tests should be requested; moreover, it should not be forgotten that more than one mechanism may be present simultaneously, for example, both congestion and hypersplenism play a role in cirrhosis.

READ FIRST — two treatable diagnoses overlooked in our country

FEVER + SPLENOMEGALY + PANCYTOPENIA → VISCERAL LEISHMANIASIS; mimics lymphoma/leukemia, diagnosed by seeing AMASTIGOTES in the bone marrow → report this possibility to the LABORATORY | SPLENOMEGALY + THROMBOCYTOPENIA, malignancy not found → GAUCHER DISEASE; GLUCOCEREBROSIDASE ENZYME ACTIVITY is simple and definitive, the disease is TREATABLE | Also BRUCELLOSIS, TUBERCULOSIS, MALARIA

Geography is a determinant in the differential diagnosis of splenomegaly, and the ranking in international sources cannot be directly applied to our country's practice. The common feature of these two diagnoses is that they mimic hematologic malignancies, and precisely for this reason, they are diagnosed late. Visceral leishmaniasis presents with prolonged fever, significant splenomegaly, and pancytopenia; the patient is naturally evaluated with suspicion of lymphoma or leukemia and is directed to a bone marrow examination. The diagnosis at this point depends on searching for amastigotes in the sample; if the clinical suspicion is not reported to the laboratory, these structures within macrophages can easily be overlooked. The disease is fatal if untreated. Gaucher disease, on the other hand, is missed in a different way: malignancies are investigated in the context of splenomegaly and thrombocytopenia, and when the results are inconclusive, the patient is followed as "idiopathic," and this follow-up can last for years. However, a single enzyme test can definitively make the diagnosis, and enzyme replacement therapy reduces organomegaly and cytopenias. In both diagnoses, the decisive factor is the recognition of the possibility.

READ FIRST — massive splenomegaly narrows the list

In MASSIVE splenomegaly, first consider: PRIMARY MYELOFIBROSIS, CHRONIC MYELOID LEUKEMIA, HAIRY CELL LEUKEMIA (monocytopenia clue!), BETA-THALASSEMIA MAJOR, GAUCHER DISEASE, VISCERAL LEISHMANIASIS, malaria-related conditions | Common feature: all are CHRONIC processes (clonal infiltration, extramedullary hematopoiesis, storage, or ongoing immune stimulation)

The degree of splenic enlargement is diagnostic information, and in practice, it is not used sufficiently. The causes of mild to moderate splenomegaly are numerous and differentiation is difficult; in contrast, massive enlargement occurs in only a few conditions where the spleen has been stimulated or filled intensely and for a long time. Therefore, when massive splenomegaly is detected, the list of possibilities is significantly narrowed, and diagnostic search accelerates. The common feature of the diseases on the list is that they are chronic: in myeloproliferative neoplasms, clonal infiltration and extramedullary hematopoiesis; in hairy cell leukemia, red pulp involvement; in major thalassemia, years of hemolysis and extramedullary hematopoiesis; in Gaucher disease, accumulation of substances in macrophages; in visceral leishmaniasis and chronic malaria, continuous immune stimulation plays a role. The accompanying monocytopenia in hairy cell leukemia is often overlooked but is a strong clue. In massive spleen, the risk of rupture and infarction also increases; in sudden abdominal pain, these possibilities should be considered.

READ FIRST — splenectomy is an irreversible decision

The spleen is UNIQUE in defense against ENCAPSULATED BACTERIA and in the clearance of abnormal cells; when removed, this function CANNOT BE REPLACED | FIRST, the underlying disease should be ATTEMPTED TO BE TREATED | In Gaucher disease, splenectomy WORSENS BONE and LUNG involvement | Pre-procedure encapsulated bacteria VACCINES should be administered, the patient should be given an ASPLENIA CARD and an emergency plan | Afterward, the risk of THROMBOSIS increases

The irreversibility of the decision for splenectomy determines the nature of this decision and requires the exhaustion of alternatives. The two functions of the spleen are especially important: opsonization against encapsulated bacteria and the removal of abnormal cells in circulation through filtration. Once these functions are removed, they cannot be fully replaced; the patient carries a lifelong risk of fulminant sepsis, and this risk is reduced with vaccination but not eliminated. Therefore, in every patient considered for splenectomy to correct cytopenias, the underlying disease should first be treated. In some diseases, this principle is even more stringent: in Gaucher's disease, the spleen acts as a buffer holding the accumulated substance, and when removed, the burden shifts to the bone and lungs, which results in improvement in blood counts but exacerbates the most debilitating aspect of the disease. When a decision is made, the most critical preparation is vaccination, and it should be planned before the procedure because the vaccine response weakens after splenectomy. In the postoperative period, platelet count increases, and the risk of portal vein thrombosis rises; this period should be monitored.

What does peripheral smear indicate in splenomegaly?

Peripheral smear in splenomegaly evaluation is an examination with almost zero cost but high diagnostic return and is often skipped. Many of the processes that enlarge the spleen also leave traces in the circulation; When these traces are read correctly, the diagnostic pathway is shortened. The presence of blasts is suggestive of acute leukemia and requires urgent evaluation. The leukoerythroblastic picture indicates impaired bone marrow structure and suggests myelofibrosis and bone marrow involvement. The coexistence of basophilia and cells from all maturation stages is suggestive of chronic myeloid leukemia and requires the desire for BCR::ABL1. Atypical lymphocytes indicate viral infections, schistocytes indicate microangiopathy, target cells indicate thalassemia and liver disease. In parasitosis such as malaria and babesiosis, the agent can be seen in direct smearing; For this reason, a thin smear with thick drops should be requested in patients with splenomegaly with fever and travel history. Finally, monocytopenia accompanying pancytopenia is a strong clue for hairy cell leukemia, a finding that is only noticeable when looking carefully at the formula.

Detailed assessment

Diagnostic and decision reasoning

Clinical framework

Overview

Splenomegaly is not a disease, but a finding with a cause behind it; Therefore, the main job is not to detect the enlarged spleen, but to find the cause. In the face of the multiplicity of causes, a list-based approach practically does not work; On the other hand, asking why the spleen is enlarged, that is, thinking based on mechanisms, makes the search manageable.

Five groups of mechanisms are distinguished. In congestion, the problem is not in the spleen itself, but in the blood outflow; portal hypertension, liver cirrhosis, heart failure, portal and splenic vein thrombosis are in this group, and liver findings and Doppler imaging are guided.

In infections, the spleen enlarges as part of the immune response; infectious mononucleosis, tuberculosis, brucellosis, infective endocarditis, visceral leishmaniasis, malaria and HIV are the main causes. In infiltration, the spleen tissue fills with abnormal cells or accumulations; lymphomas, leukemias, myeloproliferative neoplasms, amyloidosis and storage diseases are in this group, and blood count and peripheral smear are the most efficient tools.

Increased immune activity in immune and inflammatory causes enlarges the spleen. In its increased destructive function, the spleen enlarges to clear erythrocytes with a shortened lifespan and is seen in chronic hemolytic anemias.

The degree of spleen enlargement also carries diagnostic information: massive splenomegaly is seen in a few cases where the spleen has been stimulated or filled intensely for a long time, and it significantly narrows the differential diagnosis; primary myelofibrosis, chronic myeloid leukemia, hairy cell leukemia, major thalassemia, Gaucher disease, visceral leishmaniasis, and malaria-related conditions come to the forefront. In our country’s practice, visceral leishmaniasis, brucellosis, malaria, and Gaucher disease should especially be kept in mind because they are all treatable and if not considered, are diagnosed late.

The decision for splenectomy is limited to selected indications and is irreversible; vaccination against encapsulated bacteria is mandatory before the procedure, and the risk of infection and thrombosis continues lifelong afterwards.

Differential diagnosis and assessment

Key considerations

Congestive splenomegaly: liver cirrhosis and portal hypertension, portal and splenic vein thrombosis, Budd-Chiari syndrome, right heart failure, and constrictive pericarditis should be differentiated (relevant protocols).
Infectious splenomegaly: infectious mononucleosis and cytomegalovirus, tuberculosis, brucellosis, infective endocarditis, visceral leishmaniasis, malaria, HIV, typhoid, and histoplasmosis should be considered (relevant protocols).
Infiltrative splenomegaly: lymphomas, chronic lymphocytic leukemia, hairy cell leukemia, acute leukemias, primary myelofibrosis, chronic myeloid leukemia, polycythemia vera, amyloidosis, sarcoidosis, and lysosomal storage diseases should be differentiated (relevant protocols).
Hemolytic causes: hereditary spherocytosis, thalassemia syndromes, sickle cell disease (in the early period), autoimmune hemolytic anemia, and enzymopathies should be evaluated (relevant protocols).
Immune and inflammatory causes: systemic lupus erythematosus, Felty syndrome associated with rheumatoid arthritis, sarcoidosis, hemophagocytic lymphohistiocytosis, and Castleman disease should be considered (relevant protocols).
Splenomegaly with fever and pancytopenia: visceral leishmaniasis, hematologic malignancy, tuberculosis, brucellosis, hemophagocytic lymphohistiocytosis, and infective endocarditis should be differentiated.
Splenomegaly with left upper quadrant pain: splenic infarction, splenic rupture, splenic vein thrombosis, splenic abscess, and capsular tension should be considered.

Clinical decision reasoning

Why it matters

Splenomegaly is one of the topics in medicine where the distinction between 'finding and diagnosis' is most clearly seen. Detecting an enlarged spleen does not mean making a diagnosis; it only indicates the presence of a process.

The practical importance of this distinction is understood from the existence of patients monitored with the diagnosis of 'splenomegaly'; these patients can be followed for years without reaching an explanation. The value of mechanism-based grouping emerges precisely here: since the number of causes is very high, memorizing a list is useless, but asking why the spleen is enlarged directly determines which tests should be requested.

If there are signs of liver disease, Doppler and liver tests become prominent; if there is fever, microbiological evaluation; if there is a blood count disorder, flow cytometry and bone marrow examination take precedence. This approach ensures both completeness and avoidance of unnecessary test burden.

The fact that massive splenomegaly carries a separate diagnostic value is based on a biological observation: for the spleen to reach very large sizes, a long-term and intense process must exist. Therefore, massive enlargement is information that narrows the list of possibilities and accelerates the diagnostic search.

The fact that all the diseases on the list are chronic confirms this logic. Clinically, this requires that instead of roughly recording the spleen size as 'large,' it should be measured and documented through imaging; this measurement is also used in monitoring the response to treatment.

Highlighting diagnoses specific to our country shows how geography changes the differential diagnosis. If the frequency ranking from international sources is directly applied, visceral leishmaniasis, brucellosis, and malaria fall to the bottom of the list; however, these diseases occur in our country and are all treatable.

Visceral leishmaniasis is particularly instructive because the diagnosis depends on searching for amastigotes in a bone marrow examination, and this search is only conducted when the possibility is considered; reporting clinical suspicion to the laboratory directly affects diagnostic success. Gaucher disease, on the other hand, is bypassed in a different way: after excluding hematological malignancies, the patient starts to be monitored as 'idiopathic,' and enzyme testing is never requested.

In both cases, the obstacle is not diagnostic capabilities but the failure to bring the possibility to mind. The discussion of the decision for splenectomy applies the principle of 'exhausting alternatives before irreversible interventions.' The spleen's role in defense against encapsulated bacteria is unique and cannot be replaced once removed; vaccination reduces the risk but does not eliminate it.

Therefore, splenectomy performed to correct cytopenias should only be considered after the underlying disease has been treated and found insufficient. Gaucher disease is the most striking example of this principle because while splenectomy corrects blood counts, it worsens bone involvement, which is the most debilitating aspect of the disease; this shows that the improvement of a measured parameter by an intervention does not mean that it improves the course of the disease.

The necessity of vaccination before the procedure similarly emphasizes the importance of timing: the vaccine response is weaker after splenectomy, so the opportunity is before the procedure.

Safety and monitoring

Complications and safety

Critical complications

In massive splenomegaly, splenic rupture and infarction may develop; they can occur even without a history of trauma and may require emergency surgery.
Cytopenias due to hypersplenism increase the risk of bleeding and infection (relevant protocol).
After splenectomy, the lifetime risk of fulminant sepsis from encapsulated bacteria persists; vaccination reduces the risk but does not eliminate it (asplenia protocol).
Thrombocytosis and portal vein thrombosis can develop after splenectomy; early monitoring is required.
In Gaucher disease, splenectomy worsens bone and lung involvement and leads to irreversible deterioration (relevant protocol).
Failure to recognize visceral leishmaniasis results in the fatal course of a treatable disease (relevant protocol).
Leaving the diagnosis as "splenomegaly" can lead to delayed detection of underlying malignancy or infection.
Continuing contact sports in infectious mononucleosis can cause splenic rupture (relevant protocol).

Special patient populations

Special considerations

Children: the spleen is physiologically palpable, and age-appropriate normal sizes should be used; infections, hereditary hemolytic anemias, and storage diseases are emphasized.
Patients with cirrhosis: congestion and hypersplenism coexist; new and rapid enlargement should suggest portal and splenic vein thrombosis (relevant protocols).
Patients originating from endemic areas or with travel history: visceral leishmaniasis, malaria, brucellosis, and tuberculosis should be specifically evaluated (relevant protocols).
Patients with chronic hemolytic anemia (thalassemia, spherocytosis, sickle cell): splenomegaly is an expected finding; the decision for splenectomy is made based on disease-specific criteria (relevant protocols).
Adolescents and young adults diagnosed with infectious mononucleosis: warnings to avoid contact sports due to the risk of spleen rupture should be given in writing (relevant protocol).
Patients scheduled for splenectomy: vaccination should be done before the procedure, and the patient should be provided with an asplenia card and an emergency antibiotic plan (asplenia protocol).
Patients who have undergone splenectomy: should be monitored lifelong for infection risk and thrombosis; it should be explained that they need to present without delay in case of fever.
Suspected Gaucher disease: splenectomy should be avoided, and the diagnosis should be confirmed with enzyme testing (relevant protocol).

Follow-up and reassessment

Follow-up plan

In patients in whom splenomegaly is detected, the first rule of follow-up is that the diagnosis should be clarified; 'splenomegaly' should not be left as a follow-up diagnosis. In patients in whom the cause is not found in the initial evaluation, the spleen size should be documented with imaging, and blood counts along with clinical findings should be repeated at certain intervals and trends monitored.

An increase in spleen size, the appearance of new cytopenias, development of B symptoms, or new findings in the peripheral smear require repeat evaluation; in some of these patients, the underlying disease becomes apparent over time. In diagnosed patients, follow-up is carried out integrated with the monitoring of the underlying disease, and spleen size is used to assess response to treatment; therefore, it is important that the initial measurement is documented.

In treatable conditions such as myeloproliferative neoplasia, Gaucher disease, and visceral leishmaniasis, a reduction in spleen size is one of the most concrete indicators of response. Patients with massive splenomegaly should be informed about the risk of spleen rupture and infarction; they should be instructed in writing to avoid contact sports and to present without delay in case of sudden and severe abdominal pain radiating to the shoulder.

This warning should be emphasized especially in adolescents and young adults diagnosed with infectious mononucleosis. In patients planned for splenectomy, vaccination should be completed before the procedure and documented; the patient should be given a card indicating they are asplenic, and it should be clearly explained what to do in case of fever and the emergency antibiotic plan.

In the early postoperative period, platelet count and signs of thrombosis should be monitored, and portal vein thrombosis should be considered if clinical deterioration occurs with abdominal pain. Follow-up in patients who have undergone splenectomy lasts a lifetime; the vaccination schedule should be kept up to date, and the patient should inform every new physician that they are asplenic.

The common principle for all patients is as follows: changes in spleen size should be interpreted not alone, but together with blood count, clinical findings, and the course of the underlying disease.